Today (April 29), Altria Group, Inc. reported its 2025 first-quarter business results and reaffirmed its guidance for 2025 full-year adjusted diluted earnings per share (EPS).
“Our highly profitable traditional tobacco businesses performed well in a challenging environment in the first quarter,” said Billy Gifford, Altria’s Chief Executive Officer. “The smokeable products segment delivered solid adjusted operating companies income growth behind the strength of Marlboro. In the oral tobacco products segment, on! maintained momentum in a competitive marketplace as Helix invested strategically behind the brand. And shareholders continued to benefit from strong cash returns through dividends and share repurchases, while we invested in pursuit of our Vision.”
“We continue to expect to deliver a full-year 2025 adjusted diluted EPS growth rate of 2% to 5% versus 2024. This growth rate represents full-year adjusted diluted EPS in a range of $5.30 to $5.45 from a base of $5.19 in 2024. Our guidance excludes amortization expense associated with definite-lived intangible assets, which was previously included in our adjusted results.”
Highlights from the report included:
- Q1 revenue decreased 5.7% to $5.3 billion
- NJOY U.S. retail share increased 2.4 points to 6.6%
- Shipments of NJOY ACE were discontinued March 24, per ITC orders
- Paid $1.7 billion in first-quarter dividends
- Smokeable domestic shipments decreased 13.7%
- Net revenues for oral tobacco products increased by 0.5%
